Chronic B-Cell Leukemia (CBCL) Latest Advances

Find the Latest Research About Chronic B-Cell Leukemia (CBCL)

Last Updated: 06/30/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23252 publications

An indirect comparison of pirtobrutinib with second-generation covalent Bruton tyrosine kinase inhibitors in BTKi naive, and relapsed-refractory chronic lymphocytic leukemia: results of a network meta-analysis.

An indirect comparison of pirtobrutinib with second-generation covalent Bruton tyrosine kinase inhibitors in BTKi naive, and relapsed-refractory chronic lymphocytic leukemia: results of a network meta-analysis.

Journal: Leukemia & lymphoma
Published: June 21, 2026

A morphology-driven proof-of-concept study linking interphase nuclear abnormalities to dicentric-mediated genomic instability.

A morphology-driven proof-of-concept study linking interphase nuclear abnormalities to dicentric-mediated genomic instability.

Journal: Annales de biologie clinique
Published: June 20, 2026

FDA Announces Efforts to Implement Real-Time Clinical Trial Reporting.

FDA Announces Efforts to Implement Real-Time Clinical Trial Reporting.

Journal: Cancer discovery
Published: June 17, 2026

Shared decision-making, treatment priorities and communication gaps in chronic lymphocytic leukemia: an Israeli national survey.

Shared decision-making, treatment priorities and communication gaps in chronic lymphocytic leukemia: an Israeli national survey.

Journal: Leukemia & lymphoma
Published: June 16, 2026

The preclinical discovery and development of acalabrutinib for the treatment of mantle cell lymphoma.

The preclinical discovery and development of acalabrutinib for the treatment of mantle cell lymphoma.

Journal: Expert opinion on drug discovery
Published: June 15, 2026

Serine Protease HTRA1 Membranous Nephropathy With Polytypic IgG Concurrent With Plasma Cell Dyscrasia.

Serine Protease HTRA1 Membranous Nephropathy With Polytypic IgG Concurrent With Plasma Cell Dyscrasia.

Journal: Kidney medicine
Published: June 15, 2026

Composite CLL/SLL and Lymphoplasmacytic Lymphoma with IgM Anti-MAG Neuropathy: Clinicopathologic and Molecular Characterization of a Diagnostically Challenging Case.

Composite CLL/SLL and Lymphoplasmacytic Lymphoma with IgM Anti-MAG Neuropathy: Clinicopathologic and Molecular Characterization of a Diagnostically Challenging Case.

Journal: Annals of clinical and laboratory science
Published: June 08, 2026

Chimeric antigen receptor T-cell therapy induces complete remission in a patient with concurrent CLL with CNS involvement and multiple sclerosis.

Chimeric antigen receptor T-cell therapy induces complete remission in a patient with concurrent CLL with CNS involvement and multiple sclerosis.

Journal: Leukemia & lymphoma
Published: June 07, 2026

Atypical Cutaneous Manifestation Leading to the Diagnosis of Chronic Lymphocytic Leukemia.

Atypical Cutaneous Manifestation Leading to the Diagnosis of Chronic Lymphocytic Leukemia.

Journal: Cureus
Published: June 06, 2026

Sexual health and intimacy concerns among patients with chronic lymphocytic leukemia: a cross-sectional needs assessment study.

Sexual health and intimacy concerns among patients with chronic lymphocytic leukemia: a cross-sectional needs assessment study.

Journal: Leukemia & lymphoma
Published: June 05, 2026

CCL19⁺ fibroblasts define a proliferative niche in chronic lymphocytic leukemia.

CCL19⁺ fibroblasts define a proliferative niche in chronic lymphocytic leukemia.

Journal: bioRxiv : the preprint server for biology
Published: June 05, 2026

Genetic risk and immune dysregulation of classic Hodgkin lymphoma transformation of chronic lymphocytic leukemia/small lymphocytic lymphoma: a multicentric study.

Genetic risk and immune dysregulation of classic Hodgkin lymphoma transformation of chronic lymphocytic leukemia/small lymphocytic lymphoma: a multicentric study.

Journal: medRxiv : the preprint server for health sciences
Published: June 04, 2026
Showing 1-12 of 23,252

Last Updated: 06/30/2026